
Ypsomed Holding Investor Relations Material
Latest events

H2 24/25
Ypsomed Holding
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ypsomed Holding AG
Access all reports
Ypsomed Holding AG is a Switzerland-based medical device company that specializes in the design, development, and manufacture of injection and infusion systems for self-medication. It provides a wide range of products, including autoinjectors, dual chamber pens, and pen injectors, catering to various medical conditions such as diabetes, infertility, and growth disorders. Ypsomed also offers comprehensive services from design and development to manufacturing and assembly, supporting pharmaceutical and biotechnology companies throughout the product lifecycle. Ypsomed's headquarters are located in Burgdorf, Switzerland, and its shares are listed on the SWX.
Key slides for Ypsomed Holding AG


H2 24/25
Ypsomed Holding AG


H2 24/25
Ypsomed Holding AG
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
YPSN
Country
🇨🇭 Switzerland